We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.3B
Cap. Flow %
-6.85%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QLYS icon
5176
CALL
Qualys
QLYS
$5.1B
$57K ﹤0.01%
1,500
+500
+50% +$17.6K
SMOG icon
5177
VanEck Low Carbon Energy ETF
SMOG
$129M
$57K ﹤0.01%
1,026
ITI
5178
DELISTED
Iteris, Inc.
ITI
$57K ﹤0.01%
+10,394
New +$50.7K
AGRX
5179
DELISTED
Agile Therapeutics
AGRX
$57K ﹤0.01%
+9
New +$45.2K
CMD
5180
DELISTED
Cantel Medical Corporation
CMD
$57K ﹤0.01%
721
-479
-40% -$38.1K
ZAGG
5181
CALL
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$57K ﹤0.01%
7,900
+6,200
+365% +$41.6K
SEP
5182
PUT
DELISTED
Spectra Engy Parters Lp
SEP
$57K ﹤0.01%
1,300
-3,400
-72% -$152K
ASX icon
5183
ASE Group
ASX
$77.3B
$56K ﹤0.01%
8,670
CVLT icon
5184
Commault Systems
CVLT
$4.88B
$56K ﹤0.01%
1,092
-29
-3% -$1.48K
EWH icon
5185
PUT
iShares MSCI Hong Kong ETF
EWH
$1.24B
$56K ﹤0.01%
2,500
-92,100
-97% -$1.97M
IHI icon
5186
iShares US Medical Devices ETF
IHI
$3.13B
$56K ﹤0.01%
2,250
+1,380
+159% +$33.5K
LKQ icon
5187
PUT
LKQ Corp
LKQ
$5.68B
$56K ﹤0.01%
1,900
-700
-27% -$21.8K
LRMR icon
5188
Larimar Therapeutics
LRMR
$397M
$56K ﹤0.01%
995
+451
+83% +$22.4K
NUS icon
5189
CALL
Nu Skin
NUS
$252M
$56K ﹤0.01%
1,000
-17,900
-95% -$922K
STRA icon
5190
CALL
Strategic Education
STRA
$1.85B
$56K ﹤0.01%
700
UBS icon
5191
UBS Group
UBS
$173B
$56K ﹤0.01%
3,541
-3,627
-51% -$58.4K
NEWR
5192
CALL
DELISTED
New Relic, Inc.
NEWR
$56K ﹤0.01%
+1,500
New +$52.6K
SPPI
5193
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$56K ﹤0.01%
8,600
+2,700
+46% +$15.1K
PRTY
5194
DELISTED
Party City Holdco Inc.
PRTY
$56K ﹤0.01%
3,967
-4,964
-56% -$71.4K
NTRI
5195
CALL
DELISTED
NutriSystem, Inc.
NTRI
$56K ﹤0.01%
1,000
+900
+900% +$37.2K
ARCC icon
5196
CALL
Ares Capital
ARCC
$13.5B
$55K ﹤0.01%
3,192
-12,008
-79% -$207K
JKS
5197
PUT
JinkoSolar
JKS
$793M
$55K ﹤0.01%
3,300
-24,800
-88% -$393K
RM icon
5198
Regional Management Corp
RM
$301M
$55K ﹤0.01%
2,857
+2,732
+2,186% +$61.1K
SAFT icon
5199
Safety Insurance
SAFT
$1.52B
$55K ﹤0.01%
782
-1,047
-57% -$75.1K
SPXU icon
5200
ProShares UltraPro Short S&P 500
SPXU
$406M
$55K ﹤0.01%
8
-56
-88% -$407K

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.